Medication info

Metfox Sustained Release Tablet (Metformin Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
White rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201404513 · Approved 2014.09.30

This product's status changed to Expired on 2024.09.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of type 2 diabetes mellitus in adults
Who takes it
Adults
Adult dose
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be administered with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily, with both doses taken with meals. - In patients already receiving metformin tablets, the initial dose of this preparation is the same as the daily dose of immediate-release metformin tablets. Switching to this preparation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels at approximately 3-month intervals. - The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, this drug must be discontinued immediately.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of type 2 diabetes mellitus in adults

  • Inadequate blood sugar control in type 2 diabetes
View approved original text

This medication is used for adult patients with type 2 diabetes who have difficulty controlling blood sugar levels through diet and exercise alone, especially if they are overweight. It can be used alone or in combination with other oral hypoglycemic agents or insulin to aid in blood sugar management. This medication effectively controls blood sugar levels and aids in the management of diabetes.

How to take

Adult dose

The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be administered with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily, with both doses taken with meals. - In patients already receiving metformin tablets, the initial dose of this preparation is the same as the daily dose of immediate-release metformin tablets. Switching to this preparation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels at approximately 3-month intervals. - The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, this drug must be discontinued immediately.

Precautions

This medication can rarely cause a serious side effect known as lactic acidosis, which should be noted. Lactic acidosis can be fatal if it occurs during treatment, so immediate consultation with a physician is required if symptoms appear. If used together with other diabetes medications, hypoglycemia may occur, so blood sugar levels should be closely monitored. This medication should not be used in patients with moderate to severe renal impairment, dehydration, serious infections, acute myocardial infarction, or conditions that may affect renal function. Safety is advised in certain patient groups such as those with acute and unstable heart failure, patients scheduled for tests using iodinated contrast agents, patients allergic to the components of this medication, and type 1 diabetes patients. Patients with severe infections or traumatic disorders, those scheduled for surgery, patients with malnutrition or liver dysfunction should also temporarily discontinue or avoid using this medication. This medication requires cautious administration and should be paid special attention when there are irregular meals, intense exercise, or interactions with other medications. During treatment, side effects such as vitamin B12 deficiency, gastrointestinal disturbances, taste impairment, and skin rashes may occur, so any abnormal symptoms should be discussed with a doctor. Renal function should be tested before treatment and regularly; if abnormalities are found, dosage adjustment or discontinuation may be necessary. Alcohol can increase the risk of side effects from this medication, so care should be taken to avoid excessive drinking during treatment. During pregnancy, the decision to use this medication should consider its effects on the fetus and the risk of pregnancy complications; if breastfeeding, this medication is excreted in breast milk, so breastfeeding should be discontinued or drug therapy re-evaluated. Elderly patients are at higher risk of renal function decline, so appropriate dosage adjustment and regular kidney function testing are necessary. In cases of overdose, the drug can be removed through hemodialysis, so if an overdose is suspected, medical attention should be sought immediately. This medication should be swallowed whole and not chewed or crushed; the tablet shell may appear in the stool, which is normal. When taking this medication with others, consult a physician or pharmacist as interactions may alter effectiveness. It is important to monitor blood sugar levels and kidney function regularly during treatment to ensure efficacy and safety.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • vitamin B12 deficiency
  • taste disturbance
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
Show 3 more
  • itching
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness and ensure safe use.

Appearance and packaging

Appearance

White rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.